Can ADC changes help mRECIST or LI-RADS treatment response algorithm better diagnose pathological response of HCC after preoperative radiotherapy? Secondary analysis of a prospective phase 2 trial

Precise assessment of hepatocellular carcinoma response is required for patients undergoing preoperative radiotherapy. Radiotherapy induced an increase in ADC values and heightened intratumoral heterogeneity. As the delineated region of interest expanded, AUC decreased and inter-observer agreement increased. Δ-ADC<sub>slice</sub>% exhibited excellent performance in predicting pathological response and the potential to supplement existing evaluation criteria.

Authors

Institutions

Publication Details

Journal
Insights into Imaging
Published
2025-10-16
DOI
https://doi.org/10.1186/s13244-025-02090-7
Citations
1
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
1.32

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Can ADC changes help mRECIST or LI-RADS treatment response algorithm better diagnose pathological response of HCC after preoperative radiotherapy? Secondary analysis of a prospective phase 2 trial

Shuang Wang, Fan Wu, Bing Feng, Leyao Wang et al.
1 citations
Insights into Imaging
Hepatocellular Carcinoma Treatment and Prognosis
1.32
article

Can ADC changes help mRECIST or LI-RADS treatment response algorithm better diagnose pathological response of HCC after preoperative radiotherapy? Secondary analysis of a prospective phase 2 trial

Shuang Wang, Fan Wu, Bing Feng, Leyao Wang, Xiaohong Ma, Yongjian Zhu, Feng Ye, Bo Chen, Sicong Wang, Zhaowei Chen, Rong Cong, Li Zhao, Yirui Zhai
article en
1 citations

Abstract

Precise assessment of hepatocellular carcinoma response is required for patients undergoing preoperative radiotherapy. Radiotherapy induced an increase in ADC values and heightened intratumoral heterogeneity. As the delineated region of interest expanded, AUC decreased and inter-observer agreement increased. Δ-ADC<sub>slice</sub>% exhibited excellent performance in predicting pathological response and the potential to supplement existing evaluation criteria.

Insights into ImagingVol. 16(1)
General Electric (Spain) (ES), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), National Cancer Center (US)
Cancer Foundation of China
Openalex Percentile: Top 15%
Hepatocellular Carcinoma Treatment and Prognosis
1.32
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Can ADC changes help mRECIST or LI-RADS treatment response algorithm better diagnose pathological response of HCC after preoperative radiotherapy? Secondary analysis of a prospective phase 2 trial — Shuang Wang, Fan Wu, et al. · Insights into Imaging (2025) | TGRS Research Map | TGRS